“Bone Grafts and Substitutes Market Report is set to have rapid growth due to the factors, such as High awareness regarding the commercially available products, higher healthcare expenditure, and availability of advanced healthcare infrastructure at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Bone Grafts and Substitutes Market Report: By Material Type (Natural, Synthetic), By Application Type (Spinal Fusion, Craniomaxillofacial, Long Bone), By Region, And Segment Forecasts
Bone Grafts and substitutes are broadly utilized in orthopedic medical procedures for various applications. Rising instances of orthopedic issues due to weakened bones is forecasted to have higher demand in the coming future, projected from 2019-2029.
According to the United Nations Department of Economic and Social Affairs, Population Division, the number of people over the age of 60 was 841 million in 2013 and is expected to reach 2 billion in 2050. Therefore, the number of orthopedic surgeries it should increase with an increasing geriatric population that is more prone to orthopedic disorders. Therefore, it is expected that the market will see significant demand during the forecast period.
However, the risk of disease transmission and the immune response are the main factors that hinder market growth. Furthermore, the high cost of advanced products and the rigorous regulatory process involved further limit market development. Furthermore, the ethical issues associated with bone harvesting limit market growth in some regions.
The market is divided into global bone graft segments, replacing market reports based on material, application, and region.
Major applications include craniofacial, dentistry, feet and ankles, joint reconstruction, long bones, and spinal fixation. Improved reimbursement scope and the presence of a large elderly patient population are some of the factors that support market growth.
Leading companies featured in the report include: DePuy Synthes; Medtronic PLC; Nuvasive, Inc.; Orthofix Holdings, Inc.; Wright Medical Group N.V.; AlloSource, Inc.; and Stryker Corp.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.
11 October 2021
High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.
07 October 2021
Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.
06 October 2021
Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market